throbber
l\«‘l['_iJi‘pHL b HUL LIH
`!JI’llVerSlIy of Wisconsin .
`
`archives of
`
`-»1E:t:)‘5 ~:iis(3€‘.l’1
`
`Dr___ Madig()n_ w15_ 20!
`
`‘I
`l\5L 3 "
`
`2|" 5“
`1
`
`Dermatolog
`
`July 1974 Volume 110, Number 1
`
`Familial Hyperlipidemias .
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`. ..H. Fleischmaier, Y. Dowlati, .1. R. T. Reeves
`
`Bullous Pemphigoid and Dermatitis Herpetiformis .
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`. .A. M. Eng, B. Moncada
`
`Erythropoietic Protoporphyria .
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`. ..H. Schmidt, G. Snitker, K. Thomsen,
`
`.1. Lintrup
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`. .L. L. Bushkell, R. E. Jordon, R. W. Goltz
`
`Herpes Gestationis .
`
`Effects of Methotrexate and Hydroxyurea on Psoriatic Epidermis .
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`. .0. Smith,
`S. Gelfant
`
`Formaldehyde Allergy .
`
`.
`
`.
`
`.
`
`. .
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`. .W. F. Schorr, E. Keran, E. Plotka
`
`Cephalexin Therapy for Infectious Syphilis .
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`. .w. C. Duncan, J. M. Knox
`
`Haloprogin and Nystatin Therapy for Cutaneous Candidiasis .
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`. .v. H. Carter,
`S. Olansky
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`. .J. E. Fulton, Jr., G. Pablo
`
`Topical Antibacterial Therapy for Acne .
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`Cafe au Lait Spots Without Giant Pigment Granules .
`
`.
`
`.
`
`.
`
`.
`
`.
`
`. .0. N. Silvers,
`.
`.
`.
`.
`.
`.
`.
`.
`.
`.
`.
`.
`.
`Fl. S. Greenwood, E. B. Helwig
`
`congenital, Painful, Aberrant Hyponychium .
`'
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`. .n. B. Odom, K. M. Stein,
`H. I. Maibach
`
`Dermatitis Herpetiformis With Discoid Lupus Erythematosus .
`'
`
`.
`
`.
`
`.
`
`.
`
`. .P. R. Vandersteen,
`R. E. Jordon
`
`Thymoma With Systemic Lupus Erythematosus, Red Blood Cell Aplasia,
`and Herpesvirus Infection .
`.
`.
`.
`.
`.
`.
`.
`.
`.
`.
`.
`.
`.
`.
`.
`.
`. .
`.
`.
`.
`.
`. .
`.
`.
`.
`.
`.
`.
`.
`. ..M. Takigawa, M. Hayakawa
`
`Fumigant-Induced Toxic Epidermal Necrolysis .
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`. .G. F. Radimer, J. H. Davis,
`A. B. Ackerman
`
`. .K. Fisher,
`.
`.
`.
`.
`.
`.
`.
`.
`.
`Subepidermal Bullae Secondary to Escherichia coli septicemia .
`B. W. Berger, G. T. Keusch
`
`A Family Outbreak of Oral Accidental Vaccinia .
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`. .K. E. Greer, c. N. Sheap
`
`.
`
`. .W. R. Hubler, Jr., A. H. Rudolph, E. F. Daugherty
`
`Dermal Myiasis .
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`. . .
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`Human Envenomation by a Lycosid .
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`. .
`
`.
`
`.
`
`. .
`
`.
`
`. .
`
`.
`
`. .
`
`.
`
`. .
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`. ..J. F. Fledman
`
`Postacne Osteoma Cutis .
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`.
`
`. .Fl. 8. W. Basler, W. B. Taylor, D. R. Peacor
`
`. .w. B. Reed,
`.
`.
`.
`.
`.
`. .
`Kaposi Sarcoma, With Emphasis on the Internal Manifestations .
`H. M. Kamath, L. Weiss
`
`AMK
`PUBLICATION
`T
`
`CFAD V. Anacor, |PR20’|5-01776 ANACOR EX. 2197 - “I/2
`
`CFAD v. Anacor, IPR2015-01776 ANACOR EX. 2197 - 1/2
`
`

`
`This material may be protected by Copyright law (Title 17 U.S. Code)
`
`in
`to persist
`hyperesthesia tends
`some patients, and the pain continues
`in spite of the therapeutic efforts.
`In our patients suffering from the
`pain of herpes zoster, we were often
`able to give immediate relief by
`painting the lesions and the immedi-
`ately surrounding area with flexible
`collodion. Reapplication of the collo-
`dion was necessary every 12 hours for
`prolonged results.
`When applied to the skin, the ether
`of collodion evaporates and a trans-
`parent film is left. The adhesiveness
`and contractility of this film has a
`protective effect on the herpes zoster
`lesions, preventing irritation.
`Flexible collodion contains at least
`5% by weight of pyroxylin. It is color-
`less or slightly yellowish and has the
`odor of ether; on exposure to the air, a
`transparent, tenacious film forms.‘
`For years, collodion has been used
`topically for its mechanical properties
`and to hold some medications locally
`in contact with the skin. In the treat-
`ment of herpetic neuralgia, the use of
`flexible collodion successfully may res-
`urrect a valuable therapeutic tool?
`LEOPOLD KRULIG, MD
`PAUL H. JACOBS, MD
`Stanford, Calif
`
`1. Berry H, Goodwin LG: Observations on py-
`roxylin and pharmaceutical collodions. Q J Year-
`Book Pharmacy 10:23-29, 1937.
`2. Andrews GC: Diseases of the Skin. Phila-
`delphia, WB Saunders Co, 1946.
`
`Nail Damage Caused by Weed
`Killers and Insecticides
`
`To the Editor-The onychopathy
`described here, first noted by Sam-
`man and Johnston in 1969,‘
`is not
`common but very characteristic.
`On Feb 15, 1972,
`a 65-year-old
`white man used a phytosanitary prod-
`uct (Winter Volck Yellow, Sopra) for
`the treatment of fruit trees. He ne-
`glected the recommendation on the
`label and instead of mixing 1 liter of
`the product with 50 liters of water, he
`handled the chemical in a pure state
`for three hours.
`After 15 days, he noticed some
`change in the color of his nails. Two
`months later, the nails appeared to be
`made up of two portions: the proximal
`third of the nail plate was yellow and
`the distal two thirds was pink. The
`cuticle was absent and there was a
`slight painless paronychia (Figure).
`Seven months later, edema of
`the
`proximal nail fold had not completely
`
`Arch Dermatol/Vol 110, Sept 1974
`
`nail surface; irregularity of surface;
`transverse ridging and furrowing.
`Grade IV: Grossly irregular defor-
`mity of nail plate and/or loosening,
`and beginning onycholysis.
`Grade V: Loss of nail.
`The distribution of the nail lesions
`confirms that these are the result of a
`local action. The index, middle, and
`ring fingers of the right hand were
`predominantly affected and this could
`be ascribed to leakage from the knap-
`sack sprayer. Eleven of the affected
`spray operators also showed minor
`nail damage affecting the toes. How-
`ever, the only cases of toenail dam-
`age occurred in workers wearing gum
`boots, suggesting leakage from the
`sprayer down into the boots. Toenail
`damage has been encountered in bare-
`foot sprayers on coffee plantations in
`Kenya? These observations by Hearn
`and Keir“ show that dilute solutions
`in repeated use can produce the same
`damages as the concentrated ones on
`brief contact.
`Contact with weed and insect kill-
`ers in concentrated solutions or on re-
`peated usage of diluted solutions can
`produce a distinctive damage and dis-
`coloration of the nails. The proximal
`part of the nail plate becomes yellow
`or whitish. Deformity of the plate can
`lead to its loss.
`
`ROBERT L. BARAN, MD
`Cannes, France
`
`1. Samman, PD, Johnston ENM: Nail damage
`associated with handling of paraquat and diquat.
`Br Med J 1:818-819, 1969.
`2. Clarck DG, Hurst EW: The toxicity of di-
`quat. Br J Ind Med 27:51-55, 1970.
`3. Hearn CED, Keir W: Nail damage in spray
`operators exposed to paraquat. Br J Ind Med
`28:399-403, 1971.
`
`Need for Action
`
`To the Editor.—The special editorial
`by Peyton Weary that appeared in
`the April
`issue of
`the ARCHIVES
`(109:499, 1974) contained some of the
`most important information for der-
`matologists that has appeared any-
`where at any time.
`It is essential that we, as physi-
`cians and dermatologists, cooperate
`with and work with the National Pro-
`gram for Dermatology because our
`future depends on our actions in a
`myriad of ways. We whould read and
`reread this editorial to find out what
`we might and should do, and then, af-
`ter reading it, do something about it.
`ROBERT R. KIERLAND, MD
`Sun City, Ariz
`
`Letters to the Editor 467
`
`Appearance of nails after two months.
`
`disappeared. A whitish sebaceous-like
`material could be squeezed from it,
`which showed isolated or grouped ke-
`ratinocytes under microscopical ex-
`amination. There were no bacteria or
`fungi present. At this stage, the prox-
`imal yellow area made up about half
`the nail plate, indicating a slowing of
`the nail growth. The product used by
`our patient was 5% dinitro-orthocre-
`sol, which acts both as an insecticide
`and as a weed killer.
`Our patient’s condition resembled
`those of the patients who had handled
`diquat and paraquat, as described by
`Samman and Johnston. One of their
`patients had the same yellowish dis-
`coloration of the proximal part of his
`nails, whereas the two others had a
`whitish discoloration.
`Possibly, damage and discoloration
`of the nails are caused by chemicals
`reaching the nail matrix by entering
`the proximal nail fold.
`Clarck and Hurst” have studied the
`toxicity of diquat. A 20% solution
`can cause disturbance of nail growth
`when put in contact with the base of
`the nail for a few minutes. A white,
`opaque, area appears that gradually
`moves up with the growth of the nail
`until it is shed. On histologic exami-
`nation, this focus of leukonychia con-
`sists of a collection of cells that have
`retained their nuclei.
`Exposure to dilute solutions used
`for spraying may lead to harmful ef-
`fects on the nail. Hearn and Keir“ de-
`scribed nail damage in 55 out of 296
`spray operators who were exposed
`daily to diluted paraquat while work-
`ing on a sugar estate in Trinidad.
`Five grades of severity of nail dam-
`age were recognized:
`Grade I: Localized discoloration or
`transverse
`band
`of white
`dis-
`coloration affecting nail plate only.
`Grade
`II: Transverse bands of
`white discoloration afiecting two or
`more nails (the commonest lesions).
`Grade III: Nail deformity of the
`
`CFAD V. Anacor, |PR201 5-01776 ANACOR EX. 2197 - 2/2
`
`CFAD v. Anacor, IPR2015-01776 ANACOR EX. 2197 - 2/2

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket